Refine
Has Fulltext
- yes (141)
Is part of the Bibliography
- yes (141)
Year of publication
Document Type
- Journal article (121)
- Doctoral Thesis (19)
- Other (1)
Language
- English (141) (remove)
Keywords
- Neisseria meningitidis (21)
- Echinococcus (10)
- Fuchsbandwurm (6)
- Tanzania (6)
- meningococcal disease (6)
- Aspergillus (4)
- Germany (4)
- antimicrobial resistance (4)
- neisseria meningitidis (4)
- stem cells (4)
- COVID-19 (3)
- Insulin (3)
- MRSA (3)
- Meningitis (3)
- Neisseria gonorrhoeae (3)
- SARS-CoV-2 (3)
- Serotonin (3)
- infection (3)
- inflammation (3)
- meningitis (3)
- multilocularis (3)
- ARONJ (2)
- Apoptosis (2)
- BDG (2)
- Brain endothelial cells (2)
- C5aR1 (2)
- Candida auris (2)
- Echinococcosis (2)
- Fusarium (2)
- Genregulation (2)
- Group B Streptococcus (2)
- HBMEC (2)
- Haemophilus influenzae (2)
- Helicobacter pylori (2)
- Komplement <Immunologie> (2)
- MITE (2)
- MLST (2)
- Rhizopus (2)
- Stem cell (2)
- Tapeworm (2)
- Ureaplasma parvum (2)
- Ureaplasma urealyticum (2)
- alveolar echinococcosis (2)
- antigen (2)
- antigen testing (2)
- antimicrobial stewardship (2)
- bacteria (2)
- bacterial meningitis (2)
- bacterial pathogens (2)
- benzimidazole (2)
- beta-D-glucan (2)
- blood–brain barrier (2)
- brain endothelial cells (2)
- candidemia (2)
- chemotherapy (2)
- colonization (2)
- comparative genomics (2)
- diagnosis (2)
- echinococcus multilocularis (2)
- flatworm (2)
- galactomannan (2)
- gene conversion (2)
- gene expression (2)
- genome sequencing (2)
- granulocytes (2)
- haemophilus influenzae (2)
- homologous recombination (2)
- host-pathogen interaction (2)
- infection control (2)
- men who have sex with men (2)
- microbiology (2)
- neuroinflammation (2)
- neutrophils (2)
- osteonecrosis of the jaw (2)
- osteoradionecrosis (2)
- outer membrane protein (2)
- pathogens (2)
- platyhelminthes (2)
- sepsis (2)
- serology (2)
- sphingolipids (2)
- surgical site infection (2)
- tapeworm (2)
- transcriptome (2)
- 5-methyl cytosine (1)
- Abl (1)
- Acetylated tubulin (1)
- Adhäsine (1)
- Alkaline phosphatase (1)
- Alternaria (1)
- Anaphylatoxine (1)
- Anaphylatoxinrezeptoren (1)
- Argonaute (1)
- Ascaris lumbricoides (1)
- Aspergillus fumigatus (1)
- AurisID (1)
- B neisseria meningitidis (1)
- BacT/ALERT (1)
- Bacterial meningitis (1)
- Bakterielle Hirnhautentzündung (1)
- Bakterien (1)
- Bandwürmer (1)
- Benzimidazolderivate (1)
- Benzimidazoles (1)
- Biohazard (1)
- Blut-Liquor-Schranke (1)
- Brugia Malayi (1)
- C-reactive protein (1)
- C3a (1)
- C3aR (1)
- C5a (1)
- C5aR2 (1)
- CCL3 (1)
- CCL4 (1)
- CCL5 (1)
- COVID-19 testing (1)
- COVID‐19 (1)
- CPG binding domain (1)
- Calibration (1)
- Cancer treatment (1)
- Candida albicans (1)
- Candida lusitaniae (1)
- Caspase (1)
- Ceramide (1)
- Cestoda (1)
- Cestoda Taeniidae (1)
- Cestode (1)
- Chagas disease (1)
- Chemotherapie (1)
- Chemotherapy (1)
- Circinella (1)
- Clinical prediction rule (1)
- Colombia (1)
- Colonization (1)
- Community-acquired methicillin-resistant Staphylococcus aureus (1)
- Cyclo-AMP (1)
- DNA methylation (1)
- DNA recombination (1)
- Dendritic cell (1)
- Dendritische Zelle (1)
- Densovirus (1)
- Disaster response (1)
- Doxycycline (1)
- Doxyzyklin (1)
- ESBL (1)
- ET-15 clone (1)
- Echinokokkus (1)
- Efflux transport (1)
- Eingeweidewürmer (1)
- Elderly (1)
- EmERK (1)
- Emergence (1)
- Endosymbiont (1)
- Enterobacteriaceae (1)
- Entwicklung (1)
- Epigenetic (1)
- Escherichia coli K1 (1)
- Escherichia coli infections (1)
- Europe (1)
- Expansion microscopy (1)
- False positive reactions (1)
- FarR (1)
- Filariose (1)
- FinO family (1)
- Fks1 (1)
- Flagellin (1)
- Flagelline (1)
- Fox tapeworm (1)
- FoxQ2 (1)
- Fungiplex Candida Auris (1)
- GM (1)
- Genanalyse (1)
- Gene silencing (1)
- Genexpression (1)
- Genom-Vergleich (1)
- Geriatric care (1)
- Geriatrics (1)
- Germinative cell (1)
- Glutathione (1)
- Golgi (1)
- HFQ (1)
- HIV (1)
- Heilmittel (1)
- Helicobacter (1)
- Helminth (1)
- Helminths (1)
- Hfq (1)
- High throughput screening (1)
- Hirnendothelzellen (1)
- Hospital emergency plan (1)
- Host-parasite interaction (1)
- Host-pathogen interactions (1)
- I-lactate (1)
- IA (1)
- ICM (1)
- IDSA (1)
- IMD (1)
- IctP (1)
- Imatinib (1)
- Immunmodulation (1)
- Immunomodulation (1)
- In-vitro-Kultur (1)
- Inducible Clindamycin Resistance (1)
- Induzierte pluripotente Stammzelle (1)
- Infection control (1)
- Infektion (1)
- Inhibitor (1)
- Innate immunity (1)
- Jurkat cells (1)
- Kinase inhibitor (1)
- Komplement C3a (1)
- Komplement C5a (1)
- Konfokale Mikroskopie (1)
- LTR retrotransposons (1)
- Larvae (1)
- Leptomeningeal cells (1)
- Leptomeningealzellen (1)
- Lichtheimia (1)
- Listeria monocytogenes (1)
- MAP kinase (1)
- MAP-Kinase (1)
- MRONJ (1)
- MSIS (1)
- Mass critical care (1)
- Medicine (1)
- Medizin (1)
- Meningococcal infection (1)
- Meningococcal polysaccharide caccine (1)
- Meningococcal serogroup C (1)
- Meningococci (1)
- Meningokokken (1)
- Mesocestoides corti (1)
- Mesocestoides vogae (1)
- Metacestode (1)
- Methicillin resistant Staphylococcus aureus (1)
- Methicillin-resistant Staphylococcus aureus (1)
- Methicillin-resistant staphylococcus aureus (1)
- Mikrobiologie (1)
- Mobile genetic element (1)
- Mucin (1)
- Mucor (1)
- Mucorales (1)
- Multiplex PCR (1)
- Mwanza (1)
- Mycobacterium marinum (1)
- N-oleoyl serinol (1)
- NAS (1)
- NadA (1)
- Nanos (1)
- Nasal Carriage (1)
- Neisseria (1)
- Neisseria meningitdis (1)
- Neisseria meningitis (1)
- Neoblast (1)
- Nervous system (1)
- Neuroinfectiology (1)
- Neuroinflammation (1)
- Neuropeptide (1)
- Non-coding RNA (1)
- Nursing homes (1)
- ONJ (1)
- Onchozerkose (1)
- One Health (1)
- P-glycoprotein (1)
- P-gp (1)
- P. aeruginosa (1)
- PMNs (1)
- Parvovirus (1)
- Pathogenität (1)
- Pathogens (1)
- Pentastomiasis (1)
- Pneumococci (1)
- Predictive value of tests (1)
- Prevalence (1)
- ProQ (1)
- Proliferation (1)
- Protoscolex (1)
- Purpureocillium (1)
- RNA (1)
- RNA chaperone Hfq (1)
- RNA sequencing (1)
- Receptor kinase (1)
- Regulatorischer T-Lymphozyt (1)
- Regulatory T-cell (1)
- RelA (1)
- Rhizomucor (1)
- S. aureus (1)
- SARS‐CoV‐2 (1)
- SFRP (1)
- ST 772 (1)
- ST1797 (1)
- ST88 (1)
- Scedosporium (1)
- Schistosoma mansoni (1)
- Sequence motif analysis (1)
- Serum (1)
- Serumresistenz (1)
- Sierra Nevada (1)
- Signaltransduktion (1)
- Six3/6 Wnt (1)
- Skin (1)
- Small non-messenger RNS (1)
- Sphingolipide (1)
- Stammzelle (1)
- Staphylococcus aureus (1)
- Stem cells (1)
- Streptococcus agalactiae (1)
- Streptococcus suis (1)
- Stringent response (1)
- Stringente Antwort (1)
- Stringente Kontrolle (1)
- Supercoiling (1)
- Surgery (1)
- T Cells (1)
- T cells (1)
- TGF-BETA (1)
- TLR5 (1)
- TNF-alpha (1)
- Talaromyces (1)
- Telomerase (1)
- Thioredoxin (1)
- Toll like Rezeptor 4 (1)
- Toll like receptor 4 (1)
- Transkription <Genetik> (1)
- Transkriptionsregulation (1)
- Transkriptomanalyse (1)
- Transposon (1)
- Tropheryma whipplei (1)
- Tuberculosis (1)
- Typisierung (1)
- Ureaplasma (1)
- Ureaplasma species (1)
- Vaccination (1)
- Valentine Leukocidin Genes (1)
- Vesicles (1)
- Virulenzfaktor (1)
- WBC (1)
- Whipple's disease (1)
- Wolbachia (1)
- Würmer (1)
- Xenopus oocytes (1)
- Zelldifferenzierung (1)
- Zellzyklus (1)
- Zink (1)
- Zinkmangel (1)
- acute watery diarrhea (1)
- admission screening (1)
- agar (1)
- agar diffusion test (1)
- alloSCT patients (1)
- alternative pig farming (1)
- alveoar echinococcosis (1)
- ampicillin (1)
- anaphylatoxin receptors (1)
- anaphylatoxins (1)
- angeborene Immunität (1)
- anidulafungin (1)
- antero-posterior axis (1)
- antibiotic bone concentration (1)
- antibiotic prescription behavior (1)
- antibiotic use (1)
- antibodies (1)
- anticoagulants (1)
- antifungal susceptibility (1)
- antifungals (1)
- antigen-B (1)
- antigens (1)
- antimicrobial (1)
- antimicrobial responses (1)
- antimicrobials (1)
- antiresorptive drug-related osteonecrosis of the jaw (1)
- anxiety (1)
- assay (1)
- attitude of health personnel (1)
- atypical chemokine receptor 3 (1)
- aureus infections (1)
- autochthonous infection (1)
- azole resistance (1)
- bactericidal activity (1)
- beta-lactam (1)
- beta-tubulin (1)
- beta‐d‐glucan (1)
- biological techniques (1)
- biomarker (1)
- biosynthesis (1)
- blood (1)
- blood fluke (1)
- blood stream infections (1)
- blood-brain barrier (1)
- blood-cerebrospinal fluid barrier (1)
- bloodstream infection (1)
- brain barrier (1)
- brain endothelial cell (1)
- breakthrough (1)
- bronchoalveolar lavage fluid (1)
- cAMP (1)
- campylobacteriosis (1)
- cardiovascular MRI (1)
- caspase-3 (1)
- caspofungin (1)
- cell staining (1)
- cell wall (1)
- cells (1)
- central-nervous-system (1)
- cephalosporin-resistant gram-negative bacteria (1)
- ceramide (1)
- ceramide analogs (1)
- cestodes (1)
- chaperone (1)
- chemical properties (1)
- children (1)
- chorioamnionitis (1)
- choroid-plexus (1)
- circulating (1)
- coagulase-negative staphylococci (1)
- commercial kits (1)
- community settings (1)
- complement system (1)
- complex (1)
- cord blood (1)
- corticosteroids (1)
- cryptic (1)
- cutibacteria (1)
- cytokines (1)
- dRNA-seq (1)
- dendritic cells (1)
- depression (1)
- detection limits (1)
- development (1)
- differential age distribution (1)
- digital phenotyping (1)
- disease-associated (1)
- dual function (1)
- echinocandin (1)
- echinocandins (1)
- echinococcosis (1)
- ecological momentary assessment (1)
- ecology (1)
- efflux pumps (1)
- elucidation (1)
- endophthalmitis (1)
- endothelial cells (1)
- epgenetics (1)
- epidemiology (1)
- epidermal growth factor (1)
- epithelial cells (1)
- excretory-secretory (1)
- expert recommendation (1)
- extracellular (1)
- eye infection (1)
- factor H (1)
- feasibility study (1)
- field gel-electrophoreresis (1)
- flagella (1)
- flow cytometry (1)
- fluorescence microscopy (1)
- foxtapeworm (1)
- fungal antigens (1)
- fungal infection (1)
- fungal molecular diagnostics (1)
- fungi (1)
- fungicidal activity (1)
- galectin-2 (1)
- gangliosides and lipid rafts (1)
- gen (1)
- gene (1)
- general practice (1)
- general practitioner (1)
- generalized anxiety disorder (1)
- genetic loci (1)
- genetic variation (1)
- genetics (1)
- genome (1)
- genome comparison (1)
- genomic databases (1)
- genomic libraries (1)
- genomics (1)
- germinative cell (1)
- germinative cells (1)
- global regulators (1)
- globale Regulatoren (1)
- glucan synthase (1)
- glutamate dehydrogenase (1)
- glutathione (1)
- granulosus (1)
- group-B (1)
- heart (1)
- helminth (1)
- helminths (1)
- hematopoietic stem cell transplantation (1)
- hemihepatectomy (1)
- hospital-acquired methicillin-resistant Staphylococcus aureus (1)
- host defense (1)
- host response (1)
- host-pathogen interactions (1)
- host–pathogen interaction (1)
- human behaviour (1)
- human brain microvascular endothelial cells (1)
- hydatid disease (1)
- hydrogels (1)
- hyphae (1)
- identification (1)
- image processing (1)
- imaging (1)
- immune evasion (1)
- immune impairment (1)
- immune response (1)
- immunogenetics (1)
- immunology (1)
- immunomodulation (1)
- immunoprecipitation (1)
- immunotherapy (1)
- in vitro (1)
- in vivo (1)
- indigenous (1)
- induced pluripotent stem cells (1)
- infection prevention (1)
- infectious diseases management (1)
- innate immune evasions (1)
- innate immune response (1)
- insulin (1)
- interstage aspiration (1)
- intervention strategies (1)
- intravenous ceftriaxone (1)
- intravitreal vancomycin and amikacin (1)
- invasive aspergillosis (1)
- invasive disease (1)
- invasive fungal infection (1)
- invasive meningococcal disease (1)
- invasive meningococcal diseases (1)
- invasive pulmonary aspergillosis (1)
- jaw bone (1)
- joint aspiration (1)
- joint infection (1)
- keratitis (1)
- killing (1)
- kinase (1)
- knowledge (1)
- laboratory techniques and procedures (1)
- large animal models (1)
- larvae (1)
- leptomeningeal cells (1)
- leucocyte count (1)
- liver (1)
- liver resection (1)
- livestock-associated staphylococci (1)
- long noncoding RNA (1)
- longitudinal studies (1)
- mammalian genomics (1)
- mannan (1)
- marker (1)
- matrix metallopeptidase-1 (1)
- maximum liklihood (1)
- mebendazole (1)
- meningeal blood-csf barrier (1)
- meningococcal lineages (1)
- meningococcal polysaccharides (1)
- meningococci (1)
- meningococcus (1)
- metabolism (1)
- metacestode vesicles (1)
- metamorphosis (1)
- methyltransferase homolog (1)
- micafungin (1)
- mice (1)
- microRNA (1)
- microbial surface component recognising adhesive matrix molecules (1)
- microbiological culture (1)
- microbiology techniques (1)
- microscopy (1)
- microvascular endothelial cells (1)
- microvascular endothelial-cells (1)
- mitochondria (1)
- mitochondrial dynamics (1)
- mitochondrial morphology (1)
- mobile crowdsensing (1)
- mobile health (1)
- molecular characterization (1)
- molecular epidemiology (1)
- monoclonal antibody (1)
- monocytes (1)
- mouse model (1)
- mouse models (1)
- multifaceted approaches (1)
- multiple myeloma (1)
- mycobacterial infection (1)
- mycophenolic acid (1)
- myocyte (1)
- natamycin (1)
- natural killer cell (1)
- natural transformation (1)
- neglected diseases (1)
- neglected groups (1)
- nematodes (1)
- neoblast (1)
- neonatal morbidity (1)
- niche adaptation (1)
- nitrite respiration (1)
- nitrites (1)
- non-aureus staphylococci (1)
- nonautonomous (1)
- nosocomial transmission (1)
- nuclear magnetic resonance (1)
- ocular infection (1)
- one-health approach (1)
- oral cefpodoxime (1)
- oral doxycycline (1)
- oral microbiome (1)
- organic farming (1)
- organoid (1)
- outpatient (1)
- oxidative stress (1)
- panton-valentine leukocidin (1)
- paradoxical effect (1)
- paradoxical growth (1)
- parasite biology (1)
- parasitic diseases (1)
- pathometabolism (1)
- pediatric (1)
- pediatrician (1)
- periprosthetic joint infection (1)
- phase variation (1)
- phylotypic (1)
- pig (1)
- pig farming methods (1)
- piperacillin (1)
- piperacillin/tazobactam (1)
- planarian (1)
- plexus epithelial-cells (1)
- pluripotency (1)
- polymorphonuclear neutrophils (1)
- population biology (1)
- population genetics (1)
- post-operative antibiotic treatment (1)
- primary care (1)
- primary cells (1)
- probe-based real-time PCR (1)
- protein kinases (1)
- proteins (1)
- proteomic analysis (1)
- public health (1)
- qPCR (1)
- quality of life (1)
- real-time PCR (1)
- recombinant proteins (1)
- regulation (1)
- regulator (1)
- regulatory T cells (1)
- relA (1)
- research infrastructure (1)
- resistance (1)
- retrotransposition (1)
- revision arthroplasty (1)
- schistoma mansoni (1)
- sensitivity (1)
- sensitivity and specificity (1)
- septic (1)
- sequence (1)
- sequence assembly tools (1)
- serogroup B (1)
- serogroup-Y (1)
- seroprevalence (1)
- serum (1)
- serum resistance (1)
- signaltransduction (1)
- single-molecule tracking (1)
- sirolimus (1)
- small RNA (1)
- small interfering RNAs (1)
- software (1)
- spa typing (1)
- sporidia (1)
- state-based model (1)
- stem cell transplantation (1)
- strain MC58 (1)
- strain specificity (1)
- stringent response (1)
- structural determination (1)
- super-resolution microscopy (1)
- surgical intra-abdominal infections (1)
- survey (1)
- systems biology (1)
- taxonomy (1)
- tazobactam (1)
- testing strategy (1)
- therapy (1)
- thermophile (1)
- throat (1)
- tight junctions (1)
- topic ofloxacin (1)
- transcription factors (1)
- transcriptional regulation (1)
- transcriptome data analysis (1)
- transcriptomics (1)
- translational research (1)
- transplantation (1)
- transposable elements (1)
- typing (1)
- ultrahigh-field MRI (1)
- under five children (1)
- upper extremity (1)
- utilization (1)
- vaccine development (1)
- vaccines (1)
- vesicles (1)
- viral load (1)
- virulence (1)
- virulenceregulatory evolution (1)
- vitrectomy (1)
- water microbiology (1)
- white blood cell count (1)
- whole blood ex vivo model (1)
- whole-blood infection assay (1)
- whole-blood model (1)
- zinc cluster transcription factor (1)
- zinc limitation (1)
- γ-glutamyl cycle (1)
Institute
- Institut für Hygiene und Mikrobiologie (141) (remove)
Sonstige beteiligte Institutionen
- Department of Hematology and Oncology, Sana Hospital Hof, Hof, Germany (1)
- Department of Laboratory Medicine and Medicine Huddinge, Karolinska Institutet and University Hospital, Stockholm, Sweden (1)
- Department of Medicine A, University Hospital of Münster, Münster, Germany (1)
- Instituto de Higiene, Universidad de la República, Montevideo, Uruguay (1)
- Instituto de Hygiene Montevideo, Uruguay (1)
- Krankenhaushygiene und Antimicrobial Stewardship (1)
- Krankenhaushygiene und Antimicrobial Stewardship (Universitätsklinikum) (1)
- Research Center for Infectious Diseases (ZINF), University of Würzburg, Würzburg, Germany (1)
EU-Project number / Contract (GA) number
- 2016 FGR 0053 (1)
- 278864 (1)
- 715466 (1)
- 847507 (1)
In most organisms, ribosomal RNA (rRNA) contributes to >85% of total RNA. Thus, to obtain useful information from RNA-sequencing (RNA-seq) analyses at reasonable sequencing depth, typically, mature polyadenylated transcripts are enriched or rRNA molecules are depleted. Targeted depletion of rRNA is particularly useful when studying transcripts lacking a poly(A) tail, such as some non-coding RNAs (ncRNAs), most bacterial RNAs and partially degraded or immature transcripts. While several commercially available kits allow effective rRNA depletion, their efficiency relies on a high degree of sequence homology between oligonucleotide probes and the target RNA. This restricts the use of such kits to a limited number of organisms with conserved rRNA sequences. In this study we describe the use of biotinylated oligos and streptavidin-coated paramagnetic beads for the efficient and specific depletion of trypanosomal rRNA. Our approach reduces the levels of the most abundant rRNA transcripts to less than 5% with minimal off-target effects. By adjusting the sequence of the oligonucleotide probes, our approach can be used to deplete rRNAs or other abundant transcripts independent of species. Thus, our protocol provides a useful alternative for rRNA removal where enrichment of polyadenylated transcripts is not an option and commercial kits for rRNA are not available.
Migration and interactions of immune cells are routinely studied by time-lapse microscopy of in vitro migration and confrontation assays. To objectively quantify the dynamic behavior of cells, software tools for automated cell tracking can be applied. However, many existing tracking algorithms recognize only rather short fragments of a whole cell track and rely on cell staining to enhance cell segmentation. While our previously developed segmentation approach enables tracking of label-free cells, it still suffers from frequently recognizing only short track fragments. In this study, we identify sources of track fragmentation and provide solutions to obtain longer cell tracks. This is achieved by improving the detection of low-contrast cells and by optimizing the value of the gap size parameter, which defines the number of missing cell positions between track fragments that is accepted for still connecting them into one track. We find that the enhanced track recognition increases the average length of cell tracks up to 2.2-fold. Recognizing cell tracks as a whole will enable studying and quantifying more complex patterns of cell behavior, e.g. switches in migration mode or dependence of the phagocytosis efficiency on the number and type of preceding interactions. Such quantitative analyses will improve our understanding of how immune cells interact and function in health and disease.
Background
Increasing incidence of invasive infections caused by rare fungi was observed over the recent years.
Case
Here, we describe the first reported case of an infection caused by the thermophilic mold Talaromyces thermophilus. Cultivation and, hence, identification of this fastidious organism is challenging since standard incubation conditions are not sufficient. Retrospective analysis of patient samples and in vitro experiments demonstrated that testing for fungal antigens, i.e., the cell wall components galactomannan and β-1,3-D-glucan, is a promising tool.
Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research
(2023)
A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all in-vivo imaging techniques, a reduction of the number of animals per study because of the possibility to scan every animal repeatedly. We present here a solution to the dual use problem of whole-body UHF-MRI systems, which are typically installed in clinical environments, to both UHF-MRI in large animals and humans. Moreover, we provide evidence that in such a research infrastructure UHF-MRI, and ideally combined with a standard small-bore UHF-MRI system, can contribute to a variety of spatial scales in translational cardiovascular research: from cardiac organoids, Zebra fish and rodent hearts to large animal models such as pigs and humans. We present pilot data from serial CINE, late gadolinium enhancement, and susceptibility weighted UHF-MRI in a myocardial infarction model over eight weeks. In 14 pigs which were delivered from a breeding facility in a national SARS-CoV-2 hotspot, we found no infection in the incoming pigs. Human scanning using CINE and phase contrast flow measurements provided good image quality of the left and right ventricle. Agreement of functional analysis between CINE and phase contrast MRI was excellent. MRI in arrested hearts or excised vascular tissue for MRI-based histologic imaging, structural imaging of myofiber and vascular smooth muscle cell architecture using high-resolution diffusion tensor imaging, and UHF-MRI for monitoring free radicals as a surrogate for MRI of reactive oxygen species in studies of oxidative stress are demonstrated. We conclude that UHF-MRI has the potential to become an important precision imaging modality in translational cardiovascular research.
Psychosocial factors affect mental health and health-related quality of life (HRQL) in a complex manner, yet gender differences in these interactions remain poorly understood. We investigated whether psychosocial factors such as social support and personal and work-related concerns impact mental health and HRQL differentially in women and men during the first year of the COVID-19 pandemic. Between June and October 2020, the first part of a COVID-19-specific program was conducted within the “Characteristics and Course of Heart Failure Stages A-B and Determinants of Progression (STAAB)” cohort study, a representative age- and gender-stratified sample of the general population of Würzburg, Germany. Using psychometric networks, we first established the complex relations between personal social support, personal and work-related concerns, and their interactions with anxiety, depression, and HRQL. Second, we tested for gender differences by comparing expected influence, edge weight differences, and stability of the networks. The network comparison revealed a significant difference in the overall network structure. The male (N = 1370) but not the female network (N = 1520) showed a positive link between work-related concern and anxiety. In both networks, anxiety was the most central variable. These findings provide further evidence that the complex interplay of psychosocial factors with mental health and HRQL decisively depends on gender. Our results are relevant for the development of gender-specific interventions to increase resilience in times of pandemic crisis.
Pathogen-specific innate immune response patterns are distinctly affected by genetic diversity
(2023)
Innate immune responses vary by pathogen and host genetics. We analyze quantitative trait loci (eQTLs) and transcriptomes of monocytes from 215 individuals stimulated by fungal, Gram-negative or Gram-positive bacterial pathogens. We identify conserved monocyte responses to bacterial pathogens and a distinct antifungal response. These include 745 response eQTLs (reQTLs) and corresponding genes with pathogen-specific effects, which we find first in samples of male donors and subsequently confirm for selected reQTLs in females. reQTLs affect predominantly upregulated genes that regulate immune response via e.g., NOD-like, C-type lectin, Toll-like and complement receptor-signaling pathways. Hence, reQTLs provide a functional explanation for individual differences in innate response patterns. Our identified reQTLs are also associated with cancer, autoimmunity, inflammatory and infectious diseases as shown by external genome-wide association studies. Thus, reQTLs help to explain interindividual variation in immune response to infection and provide candidate genes for variants associated with a range of diseases.
Background
Haemophilus influenzae (Hi) is a Gram-negative bacterium that may cause sepsis or meningitis, treatment of which mainly includes β-lactam antibiotics. Since 2019 EUCAST breakpoints for piperacillin/tazobactam have been available. Little is known about the prevalence and mechanisms of piperacillin/tazobactam resistance in Hi.
Objectives
To provide reliable prevalence data for piperacillin/tazobactam resistance in Hi in Germany, to evaluate different antibiotic susceptibility testing methods and to examine possible resistance mechanisms.
Methods
According to EUCAST breakpoints, the MIC for piperacillin/tazobactam resistance is >0.25 mg/L. All invasive Hi in Germany from 2019 were examined by gradient agar diffusion (GAD) for piperacillin/tazobactam susceptibility. Piperacillin/tazobactam broth microdilution (BMD), piperacillin GAD on tazobactam-containing agar [piperacillin GAD on Mueller–Hinton agar with horse blood (MH-F)/tazobactam) and piperacillin/tazobactam agar dilution (AD) were used for confirmation. Phenotypic testing was complemented by ftsI sequencing.
Results
Piperacillin/tazobactam GAD resulted in 2.9% (21/726) resistant Hi. BMD did not confirm piperacillin/tazobactam resistance. Two strains were found resistant by AD, of which one was also resistant using piperacillin GAD on MH-F/tazobactam. Overall, we found two strains with a piperacillin/tazobactam MIC >0.25 mg/L in at least two different tests (0.3%). Both were β-lactamase-producing amoxicillin/clavulanate-resistant with PBP3 mutations characterized as group III-like+. Relevant PBP3 mutations occurred in six strains without phenotypic piperacillin/tazobactam resistance. These mutations suggest a reduced efficacy of β-lactam antibiotics in these isolates.
Conclusions
Piperacillin/tazobactam resistance prevalence in invasive Hi is low in Germany. Reduced susceptibility was correlated with PBP3 mutations, in particular with group III mutations.
Alveolar (AE) and cystic (CE) echinococcosis are two parasitic diseases caused by the tapeworms Echinococcus multilocularis and E. granulosus sensu lato (s. l.), respectively. Currently, AE and CE are mainly diagnosed by means of imaging techniques, serology, and clinical and epidemiological data. However, no viability markers that indicate parasite state during infection are available. Extracellular small RNAs (sRNAs) are short non-coding RNAs that can be secreted by cells through association with extracellular vesicles, proteins, or lipoproteins. Circulating sRNAs can show altered expression in pathological states; hence, they are intensively studied as biomarkers for several diseases. Here, we profiled the sRNA transcriptomes of AE and CE patients to identify novel biomarkers to aid in medical decisions when current diagnostic procedures are inconclusive. For this, endogenous and parasitic sRNAs were analyzed by sRNA sequencing in serum from disease negative, positive, and treated patients and patients harboring a non-parasitic lesion. Consequently, 20 differentially expressed sRNAs associated with AE, CE, and/or non-parasitic lesion were identified. Our results represent an in-depth characterization of the effect E. multilocularis and E. granulosus s. l. exert on the extracellular sRNA landscape in human infections and provide a set of novel candidate biomarkers for both AE and CE detection.
Background and Objective: Staphylococcus aureus is one of the major pathogens of nosocomial infections as wells as community-acquired (CA) infections worldwide. So far, large-scale comprehensive molecular and epidemiological characterisation of S. aureus from very diverse settings has not been carried out in India. The objective of this study is to evaluate the molecular, epidemiological and virulence characteristics of S. aureus in both community and hospital settings in Chennai, southern India. Methods: S. aureus isolates were obtained from four different groups (a) healthy individuals from closed community settings, (b) inpatients from hospitals, (c) outpatients from hospitals, representing isolates of hospital-community interface and (d) HIV-infected patients to define isolates associated with the immunocompromised. Antibiotic susceptibility testing, multiplex polymerase chain reactions for detection of virulence and resistance determinants, molecular typing including Staphylococcal cassette chromosome mec (SCCmec) and agr typing, were carried out. Sequencing-based typing was done using spa and multilocus sequence typing (MLST) methods. Clonal complexes (CC) of hospital and CA methicillin-resistant S. aureus (MRSA) were identified and compared for virulence and resistance.
Results and Conclusion: A total of 769 isolates of S. aureus isolates were studied. The prevalence of MRSA was found to be 7.17%, 81.67%, 58.33% and 22.85% for groups a, b, c and d, respectively. Of the four SCCmec types (I, III, IV and V) detected, SCCmec V was found to be predominant. Panton-Valentine leucocidin toxin genes were detected among MRSA isolates harbouring SCCmec IV and V. A total of 78 spa types were detected, t657 being the most prevalent. 13 MLST types belonging to 9 CC were detected. CC1 (ST-772, ST-1) and CC8 (ST238, ST368 and ST1208) were found to be predominant among MRSA. CA-MRSA isolates with SCCmec IV and V were isolated from all study groups including hospitalised patients and were found to be similar by molecular tools. This shows that CA MRSA has probably infiltrated into the hospital settings.
Neisseria meningitidis (the meningococcus) is one of the major causes of bacterial meningitis, a life-threatening inflammation of the meninges. Traversal of the meningeal blood-cerebrospinal fluid barrier (mBCSFB), which is composed of highly specialized brain endothelial cells (BECs), and subsequent interaction with leptomeningeal cells (LMCs) are critical for disease progression. Due to the human-exclusive tropism of N. meningitidis, research on this complex host-pathogen interaction is mostly limited to in vitro studies. Previous studies have primarily used peripheral or immortalized BECs alone, which do not retain relevant barrier phenotypes in culture. To study meningococcal interaction with the mBCSFB in a physiologically more accurate context, BEC-LMC co-culture models were developed in this project using BEC-like cells derived from induced pluripotent stem cells (iBECs) or hCMEC/D3 cells in combination with LMCs derived from tumor biopsies.
Distinct BEC and LMC layers as well as characteristic expression of cellular markers were observed using transmission electron microscopy (TEM) and immunofluorescence staining. Clear junctional expression of brain endothelial tight and adherens junction proteins was detected in the iBEC layer. LMC co-culture increased iBEC barrier tightness and stability over a period of seven days, as determined by sodium fluorescein (NaF) permeability and transendothelial electrical resistance (TEER). Infection experiments demonstrated comparable meningococcal adhesion and invasion of the BEC layer in all models tested, consistent with previously published data. While only few bacteria crossed the iBEC-LMC barrier initially, transmigration rates increased substantially over 24 hours, despite constant high TEER. After 24 hours of infection, deterioration of the barrier properties was observed including loss of TEER and altered expression of tight and adherens junction components. Reduced mRNA levels of ZO-1, claudin-5, and VE-cadherin were detected in BECs from all models. qPCR and siRNA knockdown data suggested that transcriptional downregulation of these genes was potentially but not solely mediated by Snail1. Immunofluorescence staining showed reduced junctional coverage of occludin, indicating N. meningitidis-induced post-transcriptional modulation of this protein, as previous studies have suggested. Together, these results suggest a potential combination of transcellular and paracellular meningococcal traversal of the mBCSFB, with the more accessible paracellular route becoming available upon barrier disruption after prolonged N. meningitidis infection. Finally, N. meningitidis induced cellular expression of pro-inflammatory cytokines and chemokines such as IL-8 in all mBCSFB models. Overall, the work described in this thesis highlights the usefulness of advanced in vitro models of the mBCSFB that mimic native physiology and exhibit relevant barrier properties to study infection with meningeal pathogens such as N. meningitidis.
Background
Colonization with Staphylococcus aureus has been identified as a risk for subsequent occurrence of infection. This study investigated the relationship between S. aureus colonization of patients and healthcare workers (HCWs), and subsequent surgical site infections (SSI).
Methods
Between December 2014 and September 2015, a total of 930 patients and 143 HCWs were enrolled from the Bugando Medical Centre and Sekou Toure hospital in Mwanza, Tanzania. On admission and discharge nasal swabs, with an additional of wound swab for those who developed SSI were collected from patients whereas HCWs were swabbed once. Identification and antimicrobial susceptibility testing were done by VITEK-MS and VITEK-2, respectively. Detection of Panton Valentine leukocidin (PVL) and mecA genes was done by PCR. S. aureus isolates were further characterized by spa typing and Multi-Locus Sequence Typing (MLST).
Results
Among 930 patients screened for S. aureus on admission, 129 (13.9%) were positive of which 5.4% (7/129) were methicillin-resistant S. aureus (MRSA). Amongst 363 patients rescreened on discharge, 301 patients had been tested negative on admission of whom 29 (9.6%) turned positive after their hospital stay. Three (10.3%) of the 29 acquired S. aureus were MRSA. Inducible Clindamycin resistance occurred more often among acquired S. aureus isolates than among isolates from admission [34.5% (10/29) vs. 17.1% (22/129), P = 0.018]. S. aureus contributed to 21.1% (n = 12) of the 57 cases of investigated SSIs among 536 patients followed. Seven out of eight S. aureus carriage/infection pairs had the same spa and sequence types. The previously reported dominant PVL-positive ST88 MRSA strain with spa type t690 was detected in patients and HCW.
Conclusion
A significant proportion of patients acquired S. aureus during hospitalization. The finding of more than 90% of S. aureus SSI to be of endogenous source underscores the need of improving infection prevention and control measures including screening and decolonization of high risk patients.
Objectives
Mechanisms of wound healing are often impaired in patients with osteonecrosis of the jaw (ONJ). According to the guidelines for the treatment of this disease, early surgical intervention is indicated. However, surgery often faces complications such as wound healing disorders. The application of platelet-rich fibrin (PRF) after necrosectomy between bone and mucosa may constitute a promising approach to improve surgical results. An aspect that was not investigated until now is that PRF acts as a “bio-carrier” for antibiotics previously applied intravenously.
Materials and methods
We investigated the antimicrobial properties of PRF in 24 patients presenting ONJ undergoing systemic antibiosis with ampicillin/sulbactam. We measured the concentration of ampicillin/sulbactam in plasma and PRF and performed agar diffusion tests. Ampicillin/sulbactam was applied intravenously to the patient 10 minutes for blood sampling for PRF. No further incorporation of patients’ blood or PRF product with antibiotic drugs was obtained. Four healthy patients served as controls.
Results
Our results revealed that PRF is highly enriched with ampicillin/sulbactam that is released to the environment. The antibiotic concentration in PRF was comparable to the plasma concentration of ampicillin/sulbactam. The inhibition zone (IZ) of PRF was comparable to the standard ampicillin/sulbactam discs used in sensitivity testing.
Conclusions
The results of our study demonstrated that PRF is a reliable bio-carrier for systemic applied antibiotics and exhibits a large antimicrobial effect.
Clinical relevance
We describe a clinically useful feature of PRF as a bio-carrier for antibiotics. Especially when applied to poorly perfused tissues and bone such as in ONJ, the local release of antibiotics can reduce wound healing disorders like infections.
Echinococcosis is an important zoonosis. The causative agent of Alveolar Echinococcosis (AE) is Echinococcus multilocularis. The treatment of human AE is limited to surgery and chemotherapy with albendazole (ABZ). However, ABZ works only parasitostatically and it needs to be taken for long periods, although it causes adverse side effects. Thus, development of new, parasiticidal drug with selective toxicity is required. Because undifferentiated stem cells of E. multilocularis play key role in its longevity and regenerative capacity, targeting stem cells is especially important.
In vitro screening of protein kinases inhibitors demonstrated that human PIM kinases inhibitors have detrimental effects on E. multilocularis. Through yeast two hybrid assay, the interaction of parasite PIM kinase (EmPIM) and its CDC25 (EmCDC25) was indicated. Through in situ hybridization, expression of EmPIM in the stem cells was observed. Therefore, EmPim is likely to be a positive regulator of cell cycle progression, the same as human Pim1. In addition, 20 compounds against EmPIM were selected through in silico screening and synthesized. One of them has a detrimental effect on E.multilocularis comparable to human pan-PIM inhibitors, but has much weaker toxicity on human cell lines.
Furthermore, triclabendazole (TCBZ) and its metabolite TCBZSX, which are approved for another flatworm disease, Fascioliasis were tried on E. multilocularis. With two stem cell markers, damage to stem cells by TCBZSX was shown. In addition, primary cells from treated vesicles never regenerated and the damage to stem cells proved to be irreversible.
Our in silico screening method used in EmPIM research has potential to identify compounds which overcome the side effect problem in ABZ-based chemotherapy. On the other hand, it is expected that my research of TCBZ can lead to development of a practical parasiticidal chemotherapy by combining TCBZ, which damages stem cells, and ABZ, which damages differentiated cells.
High seroprevalence of SARS-CoV-2 in Mwanza, northwestern Tanzania: a population-based survey
(2022)
The transmission of the SARS-CoV-2 virus, which causes COVID-19, has been documented worldwide. However, the evidence of the extent to which transmission has occurred in different countries is still to be established. Understanding the magnitude and distribution of SARS-CoV-2 through seroprevalence studies is important in designing control and preventive strategies in communities. This study investigated the seropositivity of the SARS-CoV-2 virus antibodies in the communities of three different districts in the Mwanza region, Tanzania. A household cross-sectional survey was conducted in September 2021 using the modified African Centre for Disease and Prevention (ACDC) survey protocol. A blood sample was obtained from one member of each of the selected households who consented to take part in the survey. Immunochromatographic rapid test kits were used to detect IgM and IgG SARS-CoV-2 antibodies, followed by descriptive data analysis. Overall, 805 participants were enrolled in the study with a median age of 35 (interquartile range (IQR):27–47) years. The overall SARS-CoV-2 seropositivity was 50.4% (95%CI: 46.9–53.8%). The IgG and IgM seropositivity of the SARS-CoV-2 antibodies was 49.3% and 7.2%, respectively, with 6.1% being both IgG and IgM seropositive. A history of runny nose (aOR: 1.84, 95%CI: 1.03–3.5, p = 0.036), loss of taste (aOR: 1.84, 95%CI: 1.12–4.48, p = 0.023), and living in Ukerewe (aOR: 3.55, 95%CI: 1.68–7.47, p = 0.001) and Magu (aOR: 2.89, 95%CI: 1.34–6.25, p= 0.007) were all independently associated with SARS-CoV-2 IgM seropositivity. Out of the studied factors, living in the Ukerewe district was independently associated with IgG seropositivity (aOR 1.29, CI 1.08–1.54, p = 0.004). Twenty months after the first case of COVID-19 in Tanzania, about half of the studied population in Mwanza was seropositive for SARS-CoV-2.
Candida auris was first described as a yeast pathogen in 2009. Since then, the species has emerged worldwide. In contrast to most other Candida spp., C. auris frequently exhibits multi-drug resistance and is readily transmitted in hospital settings. While most detections so far are from colonised patients, C. auris does cause superficial and life-threatening invasive infections. During management of the first documented C. auris transmission in a German hospital, experts from the National Reference Centers for Invasive Fungal Infections (NRZMyk) and the National Reference Center for Surveillance of Nosocomial Infections screened available literature and integrated available knowledge on infection prevention and C. auris epidemiology and biology to enable optimal containment. Relevant recommendations developed during this process are summarised in this guidance document, intended to assist in management of C. auris transmission and potential outbreak situations. Rapid and effective measures to contain C. auris spread require a multi-disciplinary approach that includes clinical specialists of the affected unit, nursing staff, hospital hygiene, diagnostic microbiology, cleaning staff, hospital management and experts in diagnostic mycology / fungal infections. Action should be initiated in a step-wise process and relevant interventions differ between management of singular C. auris colonised / infected patients and detection of potential C. auris transmission or nosocomial outbreaks.
Diagnosis and therapy of Mycobacterium marinum: a single-center 21-year retrospective analysis
(2022)
Background and Objectives
In Europe, infections with Mycobacterium (M.) marinum are rare. We conducted a retrospective single-center study to assess the clinical spectrum of M. marinum infection and its diagnosis, treatment and outcome under real-world conditions.
Patients and Methods
Eighteen patients presenting with M. marinum infections between 1998 and 2018 were identified in the data warehouse of the University Hospital Würzburg and considered for detailed analysis.
Results
Twelve patients reported aquatic exposure. In 16/18 cases the upper extremities were affected. No invasive infections were detected. Mean time to diagnosis was 15 weeks. Histology revealed granulomatous inflammation in 14 patients while mycobacterial cultures were positive for M. marinum in 16 cases. Most patients received antibiotic monotherapy (14/18) while combination therapy was administered in four cases. Treatment (with a median duration of 10 weeks) was successful in 13 patients. Five patients were lost to follow-up.
Conclusions
Our retrospective analysis of M. marinum infections at a German tertiary referral center revealed a considerable diagnostic delay and the relevance of microbiological culture, PCR and histology for diagnosis. Monotherapy with clarithromycin (rather than doxycycline) appeared as a reasonable treatment option while immunosuppressed or -compromised patients and those with extended disease received combination therapy.
Purpose
Fungal biomarkers support early diagnosis of invasive fungal infections. In this study, we evaluated the impact of a recent update to the manufacturer‐recommended cut‐off for beta‐1,3‐D‐glucan (BDG) testing (Fujifilm Wako BDG assay) on sensitivity and specificity for the detection of candidemia. Additionally, we compared the performance with tests for Candida antigen (Ag by Serion ELISA antigen Candida, Virion\Serion) and anti‐mannan antibodies (Ab by Hemkit Candida IHA, Ravo Diagnostika).
Methods
Sera of 82 patients with candidemia, which were sampled with a maximum distance of ±14 days from the date of sampling of the corresponding positive blood cultures, were retrospectively analysed for BDG, Ag and Ab. Results of BDG testing were compared with results from sera of 129 patients with candidemia from a different hospital.
Results
Sensitivity of BDG testing (47%) was higher than for Ag (17%) or Ab (20%). By combining Ag and Ab testing, sensitivity was raised to 32%. Lowering the cut‐off of BDG from 11 pg/ml to the newly recommended cut‐off of 7 pg/ml resulted in a significant increase in sensitivity (47% vs 58%, p = .01 and 63% vs 71% p < .01). At both centres, the increase was significant in NAC but not in C. albicans candidemia. No significant effects on specificity were observed.
Conclusion
BDG testing outperformed Ag and Ab testing and its combination. Lowering the BDG cut‐off had no significant impact on specificity. The increase in sensitivity can be mainly attributed to a gain in sensitivity for non‐albicans Candida species bloodstream infections.
The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs. In 2017 and 2018, a permanent physician was in charge for the Wiwa. Diseases and complaints were registered, ranked, and classified with the ICD-10 coding. Datasets from the Indigenous health care provider Dusakawi, collected from local health points and health brigades travelling sporadically into the fields for short visits, were compared. Furthermore, a list of provided medication was evaluated regarding the recorded needs. The most common complaints found were respiratory, infectious and parasitic, and digestive diseases. The top ten diagnoses collected in the health points and in the health brigade datasets were similar, although with a different ranking. The available medication showed a basic coverage only, with a critical lack of treatment for many severe, chronic, and life-threatening diseases. Most of the detected diseases in the Indigenous population are avoidable by an improvement in health care access, an expansion of the provided medication, and an increase in knowledge, hygiene, and life standards.
Outpatient antibiotic use is closely related to antimicrobial resistance and in Germany, almost 70% of antibiotic prescriptions in human health are issued by primary care physicians (PCPs). The aim of this study was to explore PCPs, namely General Practitioners' (GPs) and outpatient pediatricians' (PDs) knowledge of guideline recommendations on rational antimicrobial treatment, the determinants of confidence in treatment decisions and the perceived need for training in this topic in a large sample of PCPs from southern Germany. Out of 3753 reachable PCPs, 1311 completed the survey (overall response rate = 34.9%). Knowledge of guideline recommendations and perceived confidence in making treatment decisions were high in both GPs and PDs. The two highest rated influencing factors on prescribing decisions were reported to be guideline recommendations and own clinical experiences, hence patients' demands and expectations were judged as not influencing treatment decisions. The majority of physicians declared to have attended at least one specific training course on antibiotic use, yet almost all the participating PCPs declared to need more training on this topic. More studies are needed to explore how consultation-related and context-specific factors could influence antibiotic prescriptions in general and pediatric primary care in Germany beyond knowledge. Moreover, efforts should be undertaken to explore the training needs of PCPs in Germany, as this would serve the development of evidence-based educational interventions targeted to the improvement of antibiotic prescribing decisions rather than being focused solely on knowledge of guidelines.